DSM completes sale of Resins & Functional Materials businesses
Sale to Covestro agreed in September 2020 for an equity value of €1.6 billion has finalized today.
01 Apr 2021
DSM at a glance
Overview of our business & performance
A broad, global nutrition business and a focused, high-quality, specialty materials portfolio
Royal DSM is a global purpose-led, science-based company in Nutrition, Health and Sustainable Living. DSM’s purpose is to create brighter lives for all. With its products and solutions DSM addresses some of the world’s biggest challenges whilst creating simultaneously economic, environmental and societal value for all its stakeholders; customers, employees, shareholders, and society-at-large. DSM delivers innovative solutions for human nutrition, animal nutrition, personal care and aroma, medical devices, green products and applications, and new mobility and connectivity. DSM and its associated companies deliver annual net sales of about €10 billion with approximately 23,000 employees. The company was founded in 1902 and is listed on Euronext Amsterdam.
2020 key data
Group
€8,106m
Net sales
€7,998 in 2019
€1,534m
Adjusted EBITDA
€1,551 in 2019
18.9%
Adjusted EBITDA margin
19.4% in 2019
Nutrition
€6,365m
Net sales
€6,028 in 2019. >80% of group net sales
€1,338m
Adjusted EBITDA
€1,250 in 2019
21.0%
Adjusted EBITDA margin
20.7% in 2019 & an ambition of >20%
Materials
€1,518m
Net sales
€1,744 in 2019
€272m
Adjusted EBITDA
€372 in 2019
17.9%
Adjusted EBITDA margin
21.3% in 2019
People
0.24
Frequency Index of Recordable Injuries
0.28 in 2019
76%
Employee Engagement Index
74% in 2019
21%
Female executives
20% in 2019
29:71
Female:male ratio
28:72 in 2019
75%
Inclusion Index
72% in 2019
100%
Employees
offered immunity-optimizing supplements
Planet
25%
Absolute reduction
Scope 1 + 2 GHG emissions (2016 baseline)
~18%
Structural improvement
Scope 1 + 2 GHG emissions (2016 baseline)
5%
Intensity improvement
Scope 3 GHG emissions (2016 baseline)
60%
Purchased electricity
From renewable resources
5.7%
Energy efficiency
Improvement year-on-year
4.8%
Water efficiency
Improvement year-on-year
Profit
↑24%
Total Shareholder Return
vs. 2019
↑1%
Sales
continuing operations vs. 2019
↓1%
Adjusted EBITDA
continuing operations vs. 2019
€955m
Adjusted net operating free cash flow
€457m
Net profit from continuing operations
€2.40
Proposed dividend per ordinary share
Latest financial & regulatory news
-
-
DSM acquires Flavor & Fragrance bio-based intermediates business from Amyris
DSM acquires business consisting of 7 bio-based intermediate products to add to existing Aroma Ingredients portfolio.
31 Mar 2021
-
DSM announces repurchase of shares to cover stock dividend
DSM will repurchase 800,000 ordinary shares to cover commitments for the final stock dividend 2020.
16 Mar 2021
Managing Board
Geraldine Matchett, Co-CEO
Geraldine Matchett is Co-Chief Executive Officer, Chief Financial Officer and Member of the Managing Board. She was appointed as Co-CEO on 15 February 2020 and joined DSM’s Managing Board in 2014. Her current term will end in 2022.
Dimitri de Vreeze, Co-CEO
Dimitri de Vreeze is Co-Chief Executive Officer, Chief Operating Officer and Member of the Managing Board. He was appointed as Co-CEO on 15 February 2020 and joined DSM’s Managing Board in 2013. His current term will end in 2021.
Read more
-
Financial results & presentations
Instant overview of the financial results, presentations, updates & AGMs and all DSM's financial and regulatory press releases from the last decade.
-
Factbooks
An introduction for investors and analysts to DSM, our Nutrition, Materials and Innovation Center clusters and our businesses.
-
Share performance
DSM's share performance in real time and historically.